Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MT-101 |
Trade Name | |
Synonyms | MT 101|MT101 |
Drug Descriptions |
MT-101 are autologous monocytes engineered to express a chimeric antigen receptor (CAR) targeting CD5, which potentially leads to an enhanced cytotoxic T-lymphocyte (CTL) response against tumor cells expressing CD5 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187269 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cyclophosphamide + Fludarabine + MT-101 | Cyclophosphamide Fludarabine MT-101 | 0 | 1 |
MT-101 | MT-101 | 0 | 1 |